Synthesis, characterization, and bioavailability in rats of ferric phosphate nanoparticles

Journal of Nutrition

Volumn 137, Issue 3, 2007, Pages 614-619

  Rohner, Fabian ^a   Ernst, Frank O ^b   Arnold, Myrtha ^c   Hilbe, Monika ^d   Biebinger, Ralf ^a   Ehrensperger, Frank ^d   Pratsinis, Sotiris E ^b   Langhans, Wolfgang ^c   Hurrell, Richard F ^a   Zimmermann, Michael B ^a  

^a Institute of Food Science and Nutrition   (Switzerland)

^b Particle Technology Laboratory

^c ETH ZURICH   (Switzerland)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FERRIC PHOSPHATE; FERRIC SULFATE; NANOPARTICLE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; CHEMICAL STRUCTURE; CONTROLLED STUDY; DIET SUPPLEMENTATION; IN VITRO STUDY; INFLAMMATION; IRON METABOLISM; LIVER INJURY; MALE; NONHUMAN; PARTICLE SIZE; PH MEASUREMENT; PHYSICAL CHEMISTRY; PYROLYSIS; RAT; SOLUBILITY; STOICHIOMETRY; STRUCTURE ANALYSIS; SURFACE PROPERTY; TOXICOKINETICS; TRANSMISSION ELECTRON MICROSCOPY;

RATTUS;

EID: 33947122661     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/137.3.614     Document Type: Article

References (49)

1. WHO/UNICEF/UNU. Iron deficiency anaemia. Assessment, prevention and control. A guide for programme managers. Geneva: WHO; 2001.
2. Hurrell RF. Fortification: overcoming technical and practical barriers. J Nutr. 2002;132:S806-12.
3. Motzok I, Pennell MD, Davies MI, Ross HU. Effect of particle size on the biological availability of reduced iron. J Assoc Off Anal Chem. 1975;58:99-103.
4. Verma RS, Motzok I, Chen SS, Rasper J, Ross HU. Effect of storage in flour and of particle size on the bioavailability of elemental iron powders for rats and humans. J Assoc Off Anal Chem. 1977;60:759-65.
5. Cook JD, Minnich V, Moore CV, Rasmussen A, Bradley WB, Finch CA. Absorption of fortification iron in bread. Am J Clin Nutr. 1973;26:861-72.
6. Wegmuller R, Zimmermann MB, Moretti D, Arnold M, Langhans W, Hurrell RF. Particle size reduction and encapsulation affect the bioavailability of ferric pyrophosphate in rats. J Nutr. 2004;134:3301-4.
7. Fidler MC, Walczyk T, Davidsson L, Zeder C, Sakaguchi N, Juneja LR, Hurrell RF. A micronised, dispersible ferric pyrophosphate with high relative bioavailability in man. Br J Nutr. 2004;91:107-12.
8. Nanbu H, Nakata K, Sakaguchi N, Yamazaki Y, inventors. Mineral Composition. EU, European Patent EP 0870435A1. 1998.
9. Ross SA, Srinivas PR, Clifford AJ, Lee SC, Philbert MA, Hettich RL. New technologies for nutrition research. J Nutr. 2004;134:681-5.
10. Bogunia-Kubik K, Sugisaka M. From molecular biology to nanotechnology and nanomedicine. Biosystems. 2002;65:123-38.
11. Emerich DF, Thanos CG. Nanotechnology and medicine. Expert Opin Biol Ther. 2003;3:655-63.
12. Hoffart V, Lamprecht A, Maincent P, Lecompte T, Vigneron C, Ubrich N. Oral bioavailability of a low molecular weight heparin using a polymeric delivery system. J Controlled Release. 2006;113:38-42.
13. Florence AT. Issues in oral nanoparticle drug carrier uptake and targeting. J Drug Target. 2004;12:65-70.
14. Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science. 2006;311:622-7.
15. Oberdorster G, Oberdorster E, Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 2005;113:823-39.
16. Chen Z, Meng H, Xing G, Chen C, Zhao Y, Jia G, Wang T, Yuan H, Ye C, et al. Acute toxicological effects of copper nanoparticles in vivo. Toxicol Lett. 2006;163:109-20.
17. Zhang JS, Gao XY, Zhang LD, Bao YP. Biological effects of a nano red elemental selenium. Biofactors. 2001;15:27-38.
18. Wang B, Feng WY, Wang TC, Jia G, Wang M, Shi JW, Zhang F, Zhao YL, Chai ZF. Acute toxicity of nano- and micro-scale zinc powder in healthy adult mice. Toxicol Lett. 2006;161:115-23.
19. Jani P, Halbert GW, Langridge J, Florence AT. Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. J Pharm Pharmacol. 1990;42:821-6.
20. Forbes AL, Arnaud MJ, Chichester CO, Cook JD, Harrison BN, Hurrell RF, Kahn SG, Morris ER, Tanner JT, et al. Comparison of in vitro, animal, and clinical determinations of iron bioavailability: International Nutritional Anemia Consultative Group Task Force report on iron bioavailability. Am J Clin Nutr. 1989;49:225-38.
21. Pratsinis SE. Flame aerosol synthesis of ceramic powders. Prog Energy Combust Sci. 1998;24:197-219.
22. Mueller R, Madler L, Pratsinis SE. Nanoparticle synthesis at high production rates by flame spray pyrolysis. Chem Eng Sci. 2003;58:1969-76.
23. Wegner K, Pratsinis SE. Scale-up of nanoparticle synthesis in diffusion flame reactors. Chem Eng Sci. 2003;58:4581-9.
24. Madler L, Pratsinis SE. Bismuth oxide nanoparticles by flame spray pyrolysis. J Am Ceram Soc. 2002;85:1713-8.
25. Madler L, Kammler HK, Mueller R, Pratsinis SE. Controlled synthesis of nanostructured particles by flame spray pyrolysis. Aerosol Sci. 2002;33:369-89.
26. Moore JW, Anderson RC. Kinetics of the reaction of ceriumIV and arsenicIII ions. J Am Chem Soc. 1944;66:1476-9.
27. Swain JH, Newman SM, Hunt JR. Bioavailability of elemental iron powders to rats is less than bakery-grade ferrous sulfate and predicted by iron solubility and particle surface area. J Nutr. 2003;133:3546-52.
28. Fritz JC, Pla GW, Harrison BN, Clark GA. Collaborative study of rat hemoglobin repletion test for bioavailability of iron. J Assoc Off Anal Chem. 1974;57:513-7.
29. AOAC. AOAC official method 9743.1: bioavailability of iron: rat hemoglobin repletion bioassay. In: Cunniff P, editor. Official methods of analysis of AOAC International. 16th ed. Gaithersburg: AOAC International; 1997. p. 62-3.
30. Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993;123:1939-51.
31. Fluttert M, Dalm S, Oitzl MS. A refined method for sequential blood sampling by tail incision in rats. Lab Anim. 2000;34:372-8.
32. Crosby WH, Munn JI, Furth FW. Standardizing a method for clinical hemoglobinometry. US Armed Forces Med J. 1954;5:693-703.
33. Amine EK, Hegsted DM, Neff R. Biological estimation of available iron using chicks or rats. J Agric Food Chem. 1972;20:246-51.
34. Finney DJ. Efficiency in slope ratio assays. Statistical method in biological assay. 3rd ed. London: Charles Griffin & Company Ltd.; 1978. p. 214-27.
35. Finney DJ. Slope ratio assays. Statistical method in biological assay. 3rd ed. London: Charles Griffin & Company Ltd.; 1978. p. 187-213.
36. Hallberg L, Rossander-Hulthen L, Gramatkovski E. Iron fortification of flour with a complex ferric orthophosphate. Am J Clin Nutr. 1989;50:129-35.
37. Harrison BN, Pla GW, Clark GA, Fritz JC. Selection of iron sources for cereal enrichment. Cereal Chem. 1976;53:78-84.
38. Willis RB, Allen PR. Measurement of amorphous ferric phosphate to assess iron bioavailability in diets and diet ingredients. Analyst. 1999;124:425-30.
39. Volkheimer G, Schulz FH, Lindenau A, Beitz U. Persorption of metallic iron particles. Gut. 1969;10:32-3.
40. McCullough JS, Hodges GM, Dickson GR, Yarwood A, Carr KE. A morphological and microanalytical investigation into the uptake of particulate iron across the gastrointestinal tract of rats. J Submicrosc Cytol Pathol. 1995;27:119-24.
41. Hussain N, Jaitley V, Florence AT. Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics. Adv Drug Deliv Rev. 2001;50:107-42.
42. Florence AT, Hillery AM, Hussain N, Jani PU. Factors affecting the oral uptake and translocation of polystyrene nanoparticles: histological and analytical evidence. J Drug Target. 1995;3:65-70.
43. Mathiowitz E, Jacob JS, Jong YS, Carino GP, Chickering DE, Chaturvedi P, Santos CA, Vijayaraghavan K, Montgomery S, et al. Biologically erodable microspheres as potential oral drug delivery systems. Nature. 1997;386:410-4.
44. Mackenzie B, Garrick MD. Iron imports. II. Iron uptake at the apical membrane in the intestine. Am J Physiol Gastrointest Liver Physiol. 2005;289:G981-6.
45. Joo SH, Feitz AJ, Sedlak DL, Waite TD. Quantification of the oxidizing capacity of nanoparticulate zero-valent iron. Environ Sci Technol. 2005;39:1263-8.
46. Breuer W, Hershko C, Cabantchik ZI. The importance of nontransferrin bound iron in disorders of iron metabolism. Transfus Sci. 2000;23:185-92.
47. Jia X, Li N, Chen J. A subchronic toxicity study of elemental Nano-Se in Sprague-Dawley rats. Life Sci. 2005;76:1989-2003.
48. Fidler MC, Davidsson L, Zeder C, Walczyk T, Marti I, Hurrell RF. Effect of ascorbic acid and particle size on iron absorption from ferric pyrophosphate in adult women. Int J Vitam Nutr Res. 2004;74:294-300.
49. Schultz H, Madler L, Pratsinis SE, Burtscher P, Mozner N. Transparent nanocomposites of radiopaque, flame-made Ta2O5/SiO2 particles in an acrylic matrix. Adv Functional Mater. 2005;15:830-7.